These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9626794)

  • 21. Plasma Circulating Cell-free Nuclear and Mitochondrial DNA as Potential Biomarkers in the Peripheral Blood of Breast Cancer Patients.
    Mahmoud EH; Fawzy A; Ahmad OK; Ali AM
    Asian Pac J Cancer Prev; 2015; 16(18):8299-305. PubMed ID: 26745076
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients.
    Mandalà M; Moro C; Ferretti G; Calabro MG; Nolè F; Rocca A; Munzone E; Castro A; Curigliano G
    Anticancer Res; 2001; 21(1B):585-8. PubMed ID: 11299809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined measurement of the c-erbB-2 protein in breast carcinoma tissues and sera is useful as a sensitive tumor marker for monitoring tumor relapse.
    Sugano K; Ushiama M; Fukutomi T; Tsuda H; Kitoh T; Ohkura H
    Int J Cancer; 2000 Jul; 89(4):329-36. PubMed ID: 10956406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative therapy for elderly patients with breast cancer.
    von Rueden DG; Sessions SC
    Am Surg; 1994 Jan; 60(1):72-8. PubMed ID: 8273979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
    Fowble B; Hanlon AL; Patchefsky A; Freedman G; Hoffman JP; Sigurdson ER; Goldstein LJ
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):105-15. PubMed ID: 9747827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does the placement of surgical clips within the excision cavity influence local control for patients treated with breast-conserving surgery and irradiation.
    Fein DA; Fowble BL; Hanlon AL; Hoffman JP; Sigurdson ER; Eisenberg BL
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1009-17. PubMed ID: 8600083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The nature of tamoxifen action in the control of female breast cancer.
    Kodama M; Kodama T
    In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is adjuvant chemotherapy useful for women with luminal a breast cancer?
    Coates AS; Colleoni M; Goldhirsch A
    J Clin Oncol; 2012 Apr; 30(12):1260-3. PubMed ID: 22355052
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effectiveness of adjuvant systemic therapy in organ preserving treatment of pT1-2N0M0 breast cancer].
    Semiglazov VF; Kanaev SV; Bugrova IL; Vlasov AN
    Vopr Onkol; 1999; 45(5):516-9. PubMed ID: 10629708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and prognostic importance of the neutrophil lymphocyte ratio in breast cancer.
    Ozyalvacli G; Yesil C; Kargi E; Kizildag B; Kilitci A; Yilmaz F
    Asian Pac J Cancer Prev; 2014; 15(23):10363-6. PubMed ID: 25556476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of G-CSF and IL-7 in Iranian breast cancer patients.
    Bordbar E; Malekzadeh M; Ardekani MT; Doroudchi M; Ghaderi A
    Asian Pac J Cancer Prev; 2012; 13(10):5307-12. PubMed ID: 23244154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Candidate early detection protein biomarkers for ER+/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study.
    Buas MF; Rho JH; Chai X; Zhang Y; Lampe PD; Li CI
    Breast Cancer Res Treat; 2015 Sep; 153(2):445-54. PubMed ID: 26319120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating levels of endostatin in cancer patients.
    Kuroi K; Tanaka C; Toi M
    Oncol Rep; 2001; 8(2):405-9. PubMed ID: 11182064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum and immunohistochemical studies of NCC-ST-439 in breast cancer.
    Narita T; Funahashi H; Satoh Y; Imai T; Takagi H
    J Surg Oncol; 1993 Sep; 54(1):5-8. PubMed ID: 8377506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating microRNA-based screening tool for breast cancer.
    Frères P; Wenric S; Boukerroucha M; Fasquelle C; Thiry J; Bovy N; Struman I; Geurts P; Collignon J; Schroeder H; Kridelka F; Lifrange E; Jossa V; Bours V; Josse C; Jerusalem G
    Oncotarget; 2016 Feb; 7(5):5416-28. PubMed ID: 26734993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancer.
    Pedersen AC; Sørensen PD; Jacobsen EH; Madsen JS; Brandslund I
    Clin Chem Lab Med; 2013 Jul; 51(7):1511-9. PubMed ID: 23403727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic relevance of a novel multiplex immunoassay panel in breast cancer.
    Hermann N; Dressen K; Schroeder L; Debald M; Schildberg FA; Walgenbach-Bruenagel G; Hettwer K; Uhlig S; Kuhn W; Hartmann G; Holdenrieder S
    Tumour Biol; 2017 Jun; 39(6):1010428317711381. PubMed ID: 28618926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paraoxonase 1 (PON1) as a marker of short term death in breast cancer recurrence.
    Bobin-Dubigeon C; Jaffré I; Joalland MP; Classe JM; Campone M; Hervé M; Bard JM
    Clin Biochem; 2012 Nov; 45(16-17):1503-5. PubMed ID: 22659076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer.
    Ignatov A; Ignatov T; Weissenborn C; Eggemann H; Bischoff J; Semczuk A; Roessner A; Costa SD; Kalinski T
    Breast Cancer Res Treat; 2011 Jul; 128(2):457-66. PubMed ID: 21607586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast Cancer Outcomes After Diagnosis of Hormone-positive Breast Cancer and Subsequent Pregnancy in the Tamoxifen Era.
    Nye L; Rademaker A; Gradishar WJ
    Clin Breast Cancer; 2017 Jul; 17(4):e185-e189. PubMed ID: 28185739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.